Vaxcyte (PCVX) Retained Earnings (2019 - 2026)
Vaxcyte (PCVX) posted quarterly Retained Earnings of -$2.5 billion for Q1 2026, down 61.9% year-over-year from -$6.5 billion in Q1 2025, and down 14.88% quarter-over-quarter from -$2.2 billion in Q4 2025.
Vaxcyte (PCVX) Retained Earnings (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has reported Retained Earnings for 8 consecutive years, with -$2.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 61.9% year-over-year to -$2.5 billion; the TTM figure through Mar 2026 stood at -$2.5 billion (down 61.9% YoY), while the FY2025 annual figure was -$2.2 billion, down 55540.25% from the prior year.
- Retained Earnings declined to -$2.5 billion in Q1 2026 per PCVX's latest filing, from -$2.2 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $2.9 million in Q1 2024 and bottomed at -$2.5 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$579.9 million across 5 years, with a median of -$3.9 million in 2024.
- Annual changes were most pronounced in 2023 — Retained Earnings slumped 255964.27% — and 2025, when it jumped 515.83%.
- Vaxcyte's Retained Earnings stood at -$361000.0 in 2022, then plunged by 255964.27% to -$924.4 million in 2023, then jumped by 99.58% to -$3.9 million in 2024, then sank by 55540.25% to -$2.2 billion in 2025, then decreased by 14.88% to -$2.5 billion in 2026.
- Business Quant data shows PCVX's Retained Earnings at -$2.5 billion in Q1 2026, -$2.2 billion in Q4 2025, and $856000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Vaxcyte | 8.41 Bn | 8.41 Bn | - | -2.76 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.76 Bn |
| Mar 31, 2026 | -2.48 Bn |
| Dec 31, 2025 | -2.15 Bn |
| Sep 30, 2025 | 856,000.00 |
| Jun 30, 2025 | -1.89 Mn |
| Mar 31, 2025 | -1.53 Bn |
| Dec 31, 2024 | -3.87 Mn |
| Sep 30, 2024 | 139,000.00 |
| Jun 30, 2024 | -1.15 Bn |
| Mar 31, 2024 | 2.89 Mn |
| Dec 31, 2023 | -924.39 Mn |
| Sep 30, 2023 | -2.29 Mn |
| Jun 30, 2023 | -650.93 Mn |
| Mar 31, 2023 | -582.59 Mn |
| Dec 31, 2022 | -361,000.00 |
| Sep 30, 2022 | -657,000.00 |
| Jun 30, 2022 | -386.16 Mn |
| Mar 31, 2022 | -833,000.00 |
| Dec 31, 2021 | -241,000.00 |
| Sep 30, 2021 | -270.08 Mn |